VIKSX Mutual Fund

VIKSX Mutual Fund

NAV$10.79
See how much of VIKSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$2M
Expense Ratio
0.95%
Dividend Yield (Current)
-
Holdings
27
Inception Date
Dec 8, 2020
Fund Family
Virtus Investment Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+2.14%
1 Year-3.50%
3 Year+7.52%
5 Year-1.44%

Asset Allocation

Stocks: 100.00%
See how much of VIKSX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
WSTWest Pharmaceutical Services Inc6.36%
HNGEHinge Health Inc Class A6.03%
AAONAAON Inc5.43%
HEI.AHeico Corp. Class A5.41%
TDYTeledyne Technologies Inc4.83%
Top 10 Concentration: 49.34%Report Date: Jun 30, 2026
Download all 27 holdings for VIKSX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

VIKSX Mutual Fund Overview

VIKSX Mutual Fund (Virtus KAR Small-Mid Cap Growth Fund Class I) is managed by Virtus Investment Partners with $1.5M in net assets. VIKSX expense ratio is 0.95%, holding 27 positions across sectors including Industrials, Information Technology, Health Care. Inception date: 2020-12-08.

VIKSX performance shows a YTD return of 2.14%. The 1-year return is -3.50% and the 5-year return is -1.44%.

VIKSX top holdings include West Pharmaceutical Services Inc (6.4%), Hinge Health Inc Class A (6.0%), AAON Inc (5.4%), Heico Corp. Class A (5.4%), Teledyne Technologies Inc (4.8%). Go to all VIKSX holdings, VIKSX sectors, or VIKSX dividends.

VIKSX can be compared against other funds. Use VIKSX overlap to find shared positions, or VIKSX vs another fund for a side-by-side view. VIKSX alternatives are available via the screener, along with tax-loss harvesting opportunities.